Evaluation of Immunoprotection Provided by Hepatitis B Vaccine After Birth in Healthy Children

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-07-31

Study Completion Date

2021-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Worldwide, hepatitis B virus (HBV) infection is a major cause of acute hepatitis,and chronic infection with HBV often leads to chronic hepatitis, liver cirrhosis,and hepatocellular carcinoma. So far, the most effective way to prevent HBV infection in susceptible population is to inject hepatitis B vaccine. However, long-term protection against hepatitis B virus (HBV) after vaccination remains widely debated. This study aims to evaluate the existence of immune protection in healthy children with negative hepatitis B surface antibody and find a method to evaluate the immune protection induced by hepatitis B vaccine.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Efficacy of Hepatitis B Vaccine Boosters Among Neonatally Vaccinated Children in Chongqing

NCT03867643

Hepatitis B Vaccine Adverse Reaction

RECRUITING

Evaluation of Paternal, Maternal and Obstetric Factors Leading to the Hepatitis B Immunization Failure in Hong Kong

NCT02443233

Hepatitis B Infection

COMPLETED

Hepatitis B Virus Infection in Immunized Children With HBsAg-positive Parents

NCT03864263

Hepatitis b Virus Infection

UNKNOWN

A Study of the Interruption on the Mother-to-child Transmission of Hepatitis B Virus （HBV MTCT）in Newborns at High Risk

NCT02901418

Chronic Hepatitis B

UNKNOWN

Safety and Immunogenicity of Recombinant Hepatitis B Vaccines in the Neonates

NCT02764671

Hepatitis Hepatitis B Liver Diseases +1 more

UNKNOWN PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

One method to determine the long-term protection provided by hepatitis B vaccine against HBV infection is to estimate the cumulative incidence of chronic carrier status and breakthrough infection of previously vaccinated individuals in different periods. Up to now, no international standard suggests that hepatitis B vaccine should be used as a routine immunization program. However, it is an important issue to discuss the immune protection of healthy children with negative hepatitis B surface antibody and the duration of this protection in the future. Therefore, this study aims to evaluate the existence of immune protection of healthy children with negative hepatitis B surface antibody, find a method to evaluate the immune protection induced by hepatitis B vaccine.

The main content of the study: To recruit healthy children. Children lacking HBsAb were selected for immune memory test and receive a Hep B booster. The results of Antibody positive group and antibody negative group were compared and analyzed. To find out the most suitable method for evaluating immune protection.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Vaccine Reaction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Children who are 1-15 years old in Chongqing
* After birth, three injections of Hep B were inoculated in time according to the procedure of 0, 1 and 6 months(The vaccination certificate record)
* No HBV booster vaccine given since primary HBV immunization
* Children or guardian knew and agreed to accept the study
* Follow - up study and blood collection after vaccination can be accepted

Exclusion Criteria

* Unwilling or impossible to participate in this research project;
* Have a history of allergy or have had a serious vaccine reaction
* Have immune impairment diseases and appear immune impairment;
* Immunosuppressive treatment, receive any injection or oral administration of cortisone or cancer chemotherapy;
* Any kind of vaccine or any kind of observation drug has been vaccinated in the past four weeks;
* Any acute disease or other infection requiring antibiotic or antiviral treatment in the past four weeks;
* Fever symptoms occurred in the past week ( axillary temperature ≥ 38 °C)
* Blood transfusion experience;
* Has a history of more serious infectious diseases ( five types of hepatitis, AIDS, syphilis, gonorrhea, etc. );
* Hepatitis B infection or carriers(lineal relationship);
* Abnormal physical examination

Minimum Eligible Age

1 Year

Maximum Eligible Age

15 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes